142 related articles for article (PubMed ID: 22585857)
1. Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide.
Sun J; Tang DN; Fu T; Sharma P
Cancer Discov; 2012 Feb; 2(2):122-30. PubMed ID: 22585857
[TBL] [Abstract][Full Text] [Related]
2. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
[TBL] [Abstract][Full Text] [Related]
4. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
6. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
Wing K; Yamaguchi T; Sakaguchi S
Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
Chen X; Du Y; Huang Z
Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
[TBL] [Abstract][Full Text] [Related]
8. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor.
Freier E; Weber CS; Nowottne U; Horn C; Bartels K; Meyer S; Hildebrandt Y; Luetkens T; Cao Y; Pabst C; Muzzulini J; Schnee B; Brunner-Weinzierl MC; Marangolo M; Bokemeyer C; Deter HC; Atanackovic D
Psychoneuroendocrinology; 2010 Jun; 35(5):663-73. PubMed ID: 20015595
[TBL] [Abstract][Full Text] [Related]
9. CD26: a negative selection marker for human Treg cells.
Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
[TBL] [Abstract][Full Text] [Related]
10. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid.
Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS
Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910
[TBL] [Abstract][Full Text] [Related]
11. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
12. Transient attenuated Foxp3 expression on CD4⁺ T cells treated with 7D4 mAb contributes to the control of parasite burden in DBA / 2 mice infected with lethal Plasmodium chabaudi chabaudi AS.
Feng H; Zhu XT; Qi ZM; Wang QH; Wang GG; Pan YY; Li Y; Zheng L; Jiang YJ; Shang H; Cui L; Cao YM
Scand J Immunol; 2012 Jan; 75(1):46-53. PubMed ID: 21916916
[TBL] [Abstract][Full Text] [Related]
13. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
14. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
[TBL] [Abstract][Full Text] [Related]
15. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
17. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
18. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
Taylor AL; Llewelyn MJ
J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
[TBL] [Abstract][Full Text] [Related]
19. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis.
Aerts NE; Dombrecht EJ; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
Cell Immunol; 2008 Feb; 251(2):109-15. PubMed ID: 18538752
[TBL] [Abstract][Full Text] [Related]
20. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
